Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-048745

Options or other derivatives

  • CFO acquired 4,197,890 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Raines Heather CFO 2024-12-02 Grant or award · Stock Options (Right to Buy) +4,197,890 4,197,890 D
Loading xslF345X05/ownership.xml…